Pharmacokinetics of antithymocyte globulins : effects of low dose vs high dose of Thymoglobuline® in a non human primate model.
X. Préville , N. Bonnefoy-Berard , R. Buelow , J. Tiollier
Transplantation 67 ( 7)
1999
Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death
P. Mehlen , C. Kretz-Remy , X. Préville , A. P. Arrigo
The EMBO Journal 15 ( 11) 2695 -2706
702
1996
Role of Hsp27 and Related Proteins
A.-P. Arrigo , X. Préville
Stress Proteins 136 101 -132
28
1999
Yeast Virus-Derived Stimulator of the Innate Immune System Augments the Efficacy of Virus Vector-Based Immunotherapy
M.-C. Claudepierre , J. Hortelano , E. Schaedler , P. Kleinpeter
Journal of Virology 88 ( 10) 5242 -5255
9
2014
Biochemical and immunofluorescence analysis of the constitutively expressed HSP27 stress protein in monkey CV-1 cells
X. Preville , P. Mehlen , N. Fabre-Jonca , S. Chaufour
Journal of Biosciences 21 ( 2) 221 -234
11
1996
Immunosuppression in composite tissue transplantation
J. M. Dubernard , E. R. Owen , N. Lefrançois , P. Petruzzo
Immunosuppression under Trial 145 -151
1
1999
Eradication of Established Tumors by Vaccination With Recombinant Bordetella pertussis Adenylate Cyclase Carrying the Human Papillomavirus 16 E7 Oncoprotein
Daniel Ladant , Xavier Préville , Claude Leclerc , Benedikt Timmerman
Cancer Research 65 ( 2) 641 -649
100
2005
Improving administration regimens of CyaA-based vaccines using TRAP assays to detect antigen-specific CD8(+) T cells directly ex vivo.
Sandrine Daubeuf , Xavier Préville , Marie Momot , Yolande Misseri
Vaccine 27 ( 41) 5565 -5573
3
2009
Therapeutic Effects of Anti-CD115 Monoclonal Antibody in Mouse Cancer Models through Dual Inhibition of Tumor-Associated Macrophages and Osteoclasts
Laetitia Fend , Nathalie Accart , Jacqueline Kintz , Sandrine Cochin
PLoS ONE 8 ( 9) e73310
39
2013
Intravenous injection of a modified vaccinia ankara virus induces intratumoral CD8+ lymphocyte infiltration favoring tumor control in an orthotopic tumor model upon combinatorial treatment with a TLR9 agonist
Laetitia Fend , Tanja Gatard-Scheikl , Jacqueline Kintz , Murielle Gantzer
Journal for ImmunoTherapy of Cancer 2 ( Suppl 3) P57
2014
Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-βGal and MVA-MUC1 (TG4010) in a murine tumor model.
Christelle Remy-Ziller , Christine Thioudellet , Julie Hortelano , Murielle Gantzer
Human Vaccines & Immunotherapeutics 14 ( 1) 140 -145
17
2018
Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu , Takahiro Yamazaki , Erika Vacchelli , Kariman Chaba
Nature Medicine 20 ( 11) 1301 -1309
869
2014
Mammalian Small Stress Proteins Protect against Oxidative Stress through Their Ability to Increase Glucose-6-phosphate Dehydrogenase Activity and by Maintaining Optimal Cellular Detoxifying Machinery
Xavier Préville , Francesca Salvemini , Stéphane Giraud , Sylvain Chaufour
Experimental Cell Research 247 ( 1) 61 -78
274
1999
TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy
Laurent Amiset , Laetitia Fend , Tania Gatard-Scheikl , Karola Rittner
OncoImmunology 1 ( 8) 1271 -1280
13
2012
Immunological Characterization of a Modified Vaccinia Virus Ankara Vector Expressing the Human Papillomavirus 16 E1 Protein
Christelle Remy-Ziller , Claire Germain , Anita Spindler , Chantal Hoffmann
Clinical and Vaccine Immunology 21 ( 2) 147 -155
16
2014
Phosphorylation is not essential for protection of L929 cells by Hsp25 against H2O2-mediated disruption actin cytoskeleton, a protection which appears related to the redox change mediated by Hsp25.
Xavier Préville , Matthias Gaestel , André-Patrick Arrigo
Cell Stress & Chaperones 3 ( 3) 177 -187
39
1998
Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC
Caroline Tosch , Bérangère Bastien , Luc Barraud , Benoit Grellier
Journal for ImmunoTherapy of Cancer 5 ( 1) 70 -70
22
2017
Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand.
Xavier Préville , Karola Rittner , Laetitia Fend
OncoImmunology 4 ( 5)
1
2015
Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment
Laetitia Fend , Christelle Remy-Ziller , Johann Foloppe , Juliette Kempf
OncoImmunology 5 ( 2)
25
2016
Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition
Patricia Kleinpeter , Laetitia Fend , Christine Thioudellet , Michel Geist
OncoImmunology 5 ( 10)
96
2016